Cargando…
Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease
BACKGROUND: Homoarginine (hArg) has been shown to be cardioprotective in a model of ischemic heart failure; however, the mechanism remains unknown. hArg can inhibit tissue‐nonspecific alkaline phosphatase (TNAP), an enzyme that promotes vascular calcification. We hypothesized that hArg will exert be...
Autores principales: | Rodionov, Roman N., Begmatov, Hoshimjon, Jarzebska, Natalia, Patel, Ketul, Mills, Matthew T., Ghani, Zulaikha, Khakshour, Doreen, Tamboli, Pankti, Patel, Mitul N., Abdalla, Mirette, Assaf, Maryann, Bornstein, Stefan R., Millan, Jose Luis, Bode‐Böger, Stefanie M., Martens‐Lobenhoffer, Jens, Weiss, Norbert, Savinova, Olga V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662144/ https://www.ncbi.nlm.nih.gov/pubmed/31304837 http://dx.doi.org/10.1161/JAHA.119.012486 |
Ejemplares similares
-
A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2
por: Rodionov, Roman N., et al.
Publicado: (2016) -
Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism
por: Rodionov, Roman N., et al.
Publicado: (2021) -
Opposite Associations of Plasma Homoarginine and Ornithine with Arginine in Healthy Children and Adolescents
por: JaŸwińska-Kozuba, Aleksandra, et al.
Publicado: (2013) -
The Second Life of Methylarginines as Cardiovascular Targets
por: Jarzebska, Natalia, et al.
Publicado: (2019) -
Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction
por: Kleist, Christine J., et al.
Publicado: (2022)